Efficacy and Safety Study of TOLAMBA™ in Ragweed-Allergic Adults

Stopped early · Phase 2

Conditions studied: Rhinitis, Allergic, Seasonal

In brief

The purpose of this study is to find out if a new investigational vaccine, TOLAMBA™, is safe and effective in reducing the symptoms of ragweed allergy.

Key facts

Study ID
NCT00387738
Run by
Dynavax Technologies Corporation
People needed
738
Starts
2006-04-01
Expected to finish
2008-03-01
Last updated by the study team
2019-04-16

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.